FDX1
HGNC:3638 · SaudiVarKB evidence summary derived from retained literature mentions.
5Gene mentions
5Publications
0Linked variants
4Associated phenotypes
Associated phenotypes
Co-mentioned in FDX1 publications| Phenotype | Identifier | Articles | Mentions |
|---|---|---|---|
| cardiomyopathy | HP:0001638 | 1 | 1 |
| diabetes mellitus | — | 1 | 1 |
| hepatocellular carcinoma | — | 1 | 1 |
| hepatitis B | — | 1 | 1 |
Linked variants
Variants normalized to FDX1| Variant | HGVS / rsID | Articles | Mentions |
|---|
No normalized variants are linked to this gene.
Population context
Reported in the same publications| Country / region | Group | Cohort | Articles |
|---|
No structured population context is available.
Supporting publications
5 records- 2025Copper Chelation by Penicillamine Protects Against Doxorubicin-Induced Cardiomyopathy by Suppressing FDX1-Mediated Cuproptosis.BiomoleculesPubMed ↗
- 2025HMGB1/NF-κB Axis, IL-8, and Cuproptosis Contribute to Cisplatin-Induced Testicular Injury: Protective Potential Effect of Thymol.BiomoleculesPubMed ↗
- 2025Cuproptosis Contributes to Cisplatin-Induced Nephrotoxicity: Insights into Thymol's Potential Inhibitory and Protective Effects.Pharmaceuticals (Basel, Switzerland)PubMed ↗
- 2022Multi-staged gene expression profiling reveals potential genes and the critical pathways in kidney cancer.Scientific reportsPubMed ↗
- 2016Host nucleotide polymorphism in hepatitis B virus-associated hepatocellular carcinoma.World journal of hepatologyPubMed ↗